27 January 2023
Kashmeera Koh joins the Team as Biomedical Engineer.
Hire #3 of 2023 joins the QV Bioelectronics team! We are delighted to announce that Kashmeera Koh has joined QV as a Biomedical Engineer. Kashmeera is…
23 January 2023
Tomisin Olukoga joins QV as Scientist, Cancer Biology
The team keeps on growing! We’re delighted to announce the arrival of Tomisin in the role of Scientist, Cancer Biology. Tomisin is a cell biologist with…
23 January 2023
Douglas Venters Joins QV as Senior Project Engineer
Welcome to the newest Team Member! Douglas Venters Delighted to announce Doug is joining the QV Bioelectronics team as a Senior Project Engineer. ⚙️ Doug is a…
10 January 2023
QV Bioelectronics Raises £2m to Develop Revolutionary Electric Field Therapy Implant for Brain Tumour Treatment
10th January 2022, Cheshire, UK £2M Pre-Series A financing raised from new and existing VCs. The funds will facilitate the completion of pre-clinical studies and the…
8 August 2022
Sabine Ficek Joins QV Bio as new CFO
We are delighted to announce that Sabine Ficek has joined our growing team QV Bioelectronics as CFO! Sabine is a seasoned CFO with 25 years of experience within Finance…
1 June 2022
QV Bioelectronics CEO Dr Chris Bullock Gives Evidence as an Industry Expert to the All-Party Parliamentary Group on Brain Tumours (APPGBT)
The All-Party Parliamentary Group on Brain Tumours (APPGBT) held a fifth oral evidence session today as part of its ongoing inquiry, Pathway to a Cure – breaking down…

Interested in Receiving our Press Releases?





